IN2014KN00742A - - Google Patents
Info
- Publication number
- IN2014KN00742A IN2014KN00742A IN742KON2014A IN2014KN00742A IN 2014KN00742 A IN2014KN00742 A IN 2014KN00742A IN 742KON2014 A IN742KON2014 A IN 742KON2014A IN 2014KN00742 A IN2014KN00742 A IN 2014KN00742A
- Authority
- IN
- India
- Prior art keywords
- tbi
- methods
- tsi
- compositions
- therapeutics
- Prior art date
Links
- 238000000034 method Methods 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000009977 dual effect Effects 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 239000005495 thyroid hormone Substances 0.000 abstract 1
- 229940036555 thyroid hormone Drugs 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 238000011269 treatment regimen Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/046—Thyroid disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/228,705 US8986937B2 (en) | 2011-09-09 | 2011-09-09 | Compositions and methods for detecting autoantibodies |
| PCT/US2011/050976 WO2013036239A1 (en) | 2011-09-09 | 2011-09-09 | Compositions and methods for detecting autoantibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014KN00742A true IN2014KN00742A (enrdf_load_stackoverflow) | 2015-10-02 |
Family
ID=47830166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN742KON2014 IN2014KN00742A (enrdf_load_stackoverflow) | 2011-09-09 | 2011-09-09 |
Country Status (9)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020050208A1 (ja) * | 2018-09-05 | 2020-03-12 | ヤマサ醤油株式会社 | Ｔｓｈ受容体に対する自己抗体活性の迅速測定方法及びキット |
| WO2020185926A1 (en) | 2019-03-12 | 2020-09-17 | Quidel Corporation | Compositions, kits, and methods for detecting autoantibodies |
| JP7212955B2 (ja) * | 2020-12-28 | 2023-01-26 | ヤマサ醤油株式会社 | 甲状腺刺激ホルモン受容体阻害性自己抗体の活性測定法およびキット |
| CN113686841B (zh) * | 2021-09-01 | 2023-06-30 | 北京利德曼生化股份有限公司 | 定量检测甲状腺素结合力试剂盒及其制备方法、检测方法 |
| EP4519415A2 (en) | 2022-05-06 | 2025-03-12 | Antibody Analytics Limited | Chemically induced proximity systems |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4537573B2 (ja) * | 1997-09-19 | 2010-09-01 | プロメガ・コーポレイシヨン | 熱安定ルシフェラーゼと生産方法 |
| US6747139B1 (en) | 1997-11-05 | 2004-06-08 | Quest Diagnostics Investments, Inc. | Nucleic acid encoding human thyrotropin receptor |
| US8293879B2 (en) * | 2000-03-30 | 2012-10-23 | Diagnostic Hybrids, Inc. | Methods of using chimeric receptors to identify autoimmune disease |
| US8563257B2 (en) * | 2000-03-30 | 2013-10-22 | Diagnostic Hybrids, Inc. | Sensitive and rapid methods of using chimeric receptors to identify autoimmune disease and assess disease severity |
| GB0516527D0 (en) * | 2005-08-11 | 2005-09-21 | Arpi Matossian Rogers | Peptides |
| EP2080772A3 (en) * | 2005-11-21 | 2009-10-07 | Dr. Fenning Biomed GmbH | Recombinant polypeptides and methods for detecting and/or quantifying autoantibodies against TSH receptor |
| PL2121758T3 (pl) * | 2007-02-15 | 2015-02-27 | R S R Ltd | Ludzkie przeciwciała monoklonalne przeciwko receptorowi tyreotropiny, które działają jako antagoniści |
| TW200918058A (en) * | 2007-08-31 | 2009-05-01 | Organon Nv | TSH receptor antagonizing tetrahydroquinoline compounds |
| US7799532B2 (en) * | 2008-11-12 | 2010-09-21 | Hemopet | Detection and measurement of thyroid hormone autoantibodies |
| ES2545759T3 (es) * | 2008-12-24 | 2015-09-15 | Rsr Limited | Anticuerpos anti-TSHR humanos |
-
2011
- 2011-09-09 CN CN201180074180.2A patent/CN103975239B/zh active Active
- 2011-09-09 PL PL11872018T patent/PL2753928T3/pl unknown
- 2011-09-09 JP JP2014529656A patent/JP5908590B2/ja active Active
- 2011-09-09 US US13/228,705 patent/US8986937B2/en active Active
- 2011-09-09 WO PCT/US2011/050976 patent/WO2013036239A1/en active Application Filing
- 2011-09-09 KR KR1020147009182A patent/KR101872060B1/ko active Active
- 2011-09-09 DK DK11872018.4T patent/DK2753928T3/en active
- 2011-09-09 EP EP11872018.4A patent/EP2753928B1/en active Active
- 2011-09-09 IN IN742KON2014 patent/IN2014KN00742A/en unknown
-
2015
- 2015-02-18 US US14/625,086 patent/US20150233914A1/en not_active Abandoned
-
2020
- 2020-05-11 US US16/871,554 patent/US12174185B2/en active Active
-
2023
- 2023-12-06 US US18/530,800 patent/US20240133882A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20200340991A1 (en) | 2020-10-29 |
| US12174185B2 (en) | 2024-12-24 |
| EP2753928A4 (en) | 2015-05-27 |
| US20130065252A1 (en) | 2013-03-14 |
| JP5908590B2 (ja) | 2016-04-26 |
| EP2753928B1 (en) | 2018-02-07 |
| JP2014529993A (ja) | 2014-11-17 |
| CN103975239A (zh) | 2014-08-06 |
| WO2013036239A1 (en) | 2013-03-14 |
| US8986937B2 (en) | 2015-03-24 |
| KR20140084022A (ko) | 2014-07-04 |
| DK2753928T3 (en) | 2018-05-22 |
| US20150233914A1 (en) | 2015-08-20 |
| CN103975239B (zh) | 2016-08-24 |
| EP2753928A1 (en) | 2014-07-16 |
| US20240133882A1 (en) | 2024-04-25 |
| PL2753928T3 (pl) | 2018-07-31 |
| KR101872060B1 (ko) | 2018-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2300008I1 (hu) | Bispecifikus anti-VEGF/anti-ANG-2 antitestek és ezek alkalmazása szemészeti érbetegségek kezelésében | |
| WO2015031808A3 (en) | Diagnostic methods and compositions for treatment of glioblastoma | |
| PH12012502231A1 (en) | Anti-human trop-2 antibody having antitumor activity in vivo | |
| ZA201202076B (en) | Anti-cmet antibody and its use for the detection and the diagnosis of cancer | |
| HUE045724T2 (hu) | GRPR antagonisták GRPR-pozitív rák kimutatására, diagnózisára és kezelésére | |
| MX2013000675A (es) | Metodo para identificar a un paciente con incrementada probabilidad de responder a una terapia anticancer. | |
| EP2539470A4 (en) | DIAGNOSIS, PROGNOSIS AND TREATMENT PROCEDURE FOR AUTOIMMUNE DISEASES | |
| EP2652506A4 (en) | USE OF ANTIBODIES AGAINST CXCL16 AND CXCR6 FOR TREATMENT OR FOR THE DETECTION OF CANCER | |
| DK3088421T3 (da) | Monoklonale antistoffer til anvendelse i diagnose og terapi af cancer-sygdomme og autoimmunsygdomme | |
| EP2817621A4 (en) | PROOF OF ANTI-MÜLLER-HORMON IN FULL BLOOD | |
| MY201478A (en) | Antibodies and assays for detection of folate receptor 1 | |
| EP2667237A4 (en) | DEVICE AND METHOD FOR THE INVESTIGATION, DIAGNOSIS OR DIAGNOSTIC ASSISTANCE AND THERAPY OF FUNCTIONAL VISIBILITY PROBLEMS | |
| MX2015015784A (es) | Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino. | |
| EP2811832A4 (en) | USE OF LAQUINIMOD FOR THE TREATMENT OF PATIENTS WITH MORBUS CROHN AFTER FAILED PREVIOUS ANTI-TNF THERAPY | |
| EP2785877A4 (en) | DEVICE AND METHOD FOR REMOTE MEASUREMENT OF BLOOD IN HUMAN CHAIR AND URINE | |
| SG11201703202YA (en) | Method and system for detection of disease agents in blood | |
| EP2631649A4 (en) | METHOD AND DEVICE FOR FAST DIAGNOSIS OF DISEASES IN FAKE SAMPLE | |
| IN2014KN00742A (enrdf_load_stackoverflow) | ||
| GB2489717B (en) | Device and method for the detection of blood analytes | |
| MX385216B (es) | Prueba de diagnostico basada en fragmento de rgma. | |
| PH12017502099B1 (en) | Methods for diagnosing and assessing treatment for cushing's syndrome | |
| FR2979346B1 (fr) | Nanocorps anti-vcam-1 | |
| HK1244881A1 (zh) | 建立维多珠单坑给药方案以治疗患有易激惹肠病的患者的方法 | |
| WO2016014799A9 (en) | Epidermal growth factor and blockade of immune checkpoints in cancer immunotherapy | |
| EP2528939A4 (en) | RECOMBINANT PROTEINS FOR USE IN VACCINES, ANTIBODIES TO THESE PROTEINS, AND DIAGNOSTIC AND THERAPEUTIC PROCEDURES THEREWITH |